Women are unaware of pregnancy risks linked with sodium valproateBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5829 (Published 31 October 2016) Cite this as: BMJ 2016;355:i5829
- Zosia Kmietowicz
- The BMJ
Doctors are being asked to make sure that women and girls with epilepsy know about the risks of taking sodium valproate during pregnancy, after a survey found that half of those questioned were unaware that it could harm the fetus.
The charities Epilepsy Action, Epilepsy Society, and Young Epilepsy conducted a survey earlier this year, in conjunction with the Medicines and Healthcare Products Regulatory Agency (MHRA), of 2788 women aged 16 to 50 with epilepsy.
It found that one in five (20%) women currently taking sodium …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial